KDM4D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.498200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.852800E-01
Normal-vs-Stage2
1.050020E-02
Normal-vs-Stage3
2.500200E-02
Normal-vs-Stage4
5.864200E-02
Stage1-vs-Stage2
1.965560E-01
Stage1-vs-Stage3
1.362000E-01
Stage1-vs-Stage4
2.733400E-01
Stage2-vs-Stage3
2.836600E-01
Stage2-vs-Stage4
5.928400E-01
Stage3-vs-Stage4
6.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.673600E-02
Normal-vs-AfricanAmerican
2.714100E-02
Normal-vs-Asian
6.731600E-02
Caucasian-vs-AfricanAmerican
7.821600E-01
Caucasian-vs-Asian
9.333600E-01
AfricanAmerican-vs-Asian
8.473800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.844200E-03
Normal-vs-Female
8.163600E-02
Male-vs-Female
1.667820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.031800E-01
Normal-vs-Age(41-60Yrs)
8.465800E-02
Normal-vs-Age(61-80Yrs)
1.173900E-02
Normal-vs-Age(81-100Yrs)
3.624000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.475200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.771400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.389000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.151800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.092400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.201900E-03
Normal-vs-Daily Drinker
1.022100E-02
Normal-vs-Weekly Drinker
3.491900E-02
Normal-vs-Occasional Drinker
7.727700E-02
Normal-vs-Social Drinker
5.656000E-01
Non Drinker-vs-Daily Drinker
5.941800E-01
Non Drinker-vs-Weekly Drinker
6.184400E-01
Non Drinker-vs-Occasional Drinker
1.778190E-01
Non Drinker-vs-Social Drinker
4.188100E-02
Daily Drinker-vs-Weekly Drinker
9.531600E-01
Daily Drinker-vs-Occasional Drinker
3.953400E-01
Daily Drinker-vs-Social Drinker
7.466000E-02
Weekly Drinker-vs-Occasional Drinker
5.170000E-01
Weekly Drinker-vs-Social Drinker
1.035170E-01
Occasional Drinker-vs-Social Drinker
1.986770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.238400E-01
Normal-vs-Grade 2
8.802600E-01
Normal-vs-Grade 3
9.820200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.708200E-01
Grade 1-vs-Grade 3
6.784200E-01
Grade 1-vs-Grade 4
9.238400E-01
Grade 2-vs-Grade 3
6.080100E-02
Grade 2-vs-Grade 4
8.802600E-01
Grade 3-vs-Grade 4
9.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.684000E-03
Normal-vs-NonDiabetic
4.593800E-02
Diabetic-vs-NonDiabetic
1.474640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.088000E-01
Normal-vs-NoPancreatitis
2.266100E-02
Pancreatitis-vs-NoPancreatitis
6.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.426850E-01
Normal-vs-N1
3.143600E-03
N0-vs-N1
1.158960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.708020E-01
Normal-vs-TP53-NonMutant
1.693620E-01
TP53-Mutant-vs-TP53-NonMutant
9.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
